Nuvalent (NUVL)
(Delayed Data from NSDQ)
$77.52 USD
-2.02 (-2.54%)
Updated Sep 25, 2025 04:00 PM ET
After-Market: $77.50 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Nuvalent, Inc. has a market cap of $5.74B, which represents its share price of $79.54 multiplied by its outstanding shares number of 72.11M. As a mid-cap company, NUVL's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NUVL 77.52 -2.02(-2.54%)
Will NUVL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NUVL based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NUVL
Is NUVL consolidating before a move? Bollinger Band Squeeze shows up after sinking 1.9%
NUVL forms 20 Day Moving Average Support on September 23
Barclays Keeps Their Buy Rating on Nuvalent (NUVL)
COMMODORE CAPITAL LP Acquires 1,225,000 Shares in LB Pharmaceuticals Inc
Crossed Above 20 Day Moving Average appears for NUVL after 2.91% move